Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization

Pathogenic neoangiogenesis in Alzheimer's disease (AD) is due to amyloid-beta (Aβ) and results in blood-brain barrier (BBB) leakiness in AD. It likely occurs as a compensatory response to impaired cerebral blood flow and provides a strong link between brain vascularity and AD. Aβ immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Biron, Kaan E., Dickstein, Dara L., Gopaul, Rayshad, Fenninger, Franz, Jefferies, Wilfred A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584312/
https://www.ncbi.nlm.nih.gov/pubmed/23446889
http://dx.doi.org/10.1038/srep01354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584312/
https://www.ncbi.nlm.nih.gov/pubmed/23446889
http://dx.doi.org/10.1038/srep01354

Ejemplares similares